Free. Unsubscribe any time.
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. filed 12 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 1 reporting owner, covering 24 transactions and 252,000 shares. 12 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-03-17, came 28 days after the one before it (2026-02-17) and reports 4 transactions against 4 in the filing before it.
- The sales it reports total 21,000 shares, the same as the 21,000 in the filing before it.
- Its 12 plan statements rank 358th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 12 filings on file run from 2025-03-21 to 2026-03-17, and state 2 plan adoption dates, from 2024-12-05 to 2025-11-14.
Trades in ADMA BIOLOGICS, INC. 24
- Grossman Adam S — 2025-03-19 · S · 15,000 shares
- Grossman Adam S — 2025-03-19 · S · 6,000 shares
- Grossman Adam S — 2025-04-15 · S · 15,000 shares
- Grossman Adam S — 2025-04-15 · S · 6,000 shares
- Grossman Adam S — 2025-05-15 · S · 15,000 shares
- Grossman Adam S — 2025-05-15 · S · 6,000 shares
- Grossman Adam S — 2025-06-16 · S · 15,000 shares
- Grossman Adam S — 2025-06-16 · S · 6,000 shares
- Grossman Adam S — 2025-07-15 · S · 15,000 shares
- Grossman Adam S — 2025-07-15 · S · 6,000 shares
- Grossman Adam S — 2025-08-15 · S · 15,000 shares
- Grossman Adam S — 2025-08-15 · S · 6,000 shares
Adoption dates in ADMA BIOLOGICS, INC. 2
- 2024-12-05 — stated in 10 filings
- 2025-11-14 — stated in 2 filings
Results prints in ADMA BIOLOGICS, INC. 9
- 2025-01-13
- 2025-03-03
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-01-12
- 2026-02-25
- 2026-05-06
- 2026-08-05
Trades before a print in ADMA BIOLOGICS, INC. 0
- 8 days before the 2026-02-25 print — 2026-02-17 · S · Grossman Adam S · 15,000 shares
- 8 days before the 2026-02-25 print — 2026-02-17 · S · Grossman Adam S · 6,000 shares
- 12 days before the 2025-11-05 print — 2025-10-24 · S · Grossman Adam S · 15,000 shares
- 12 days before the 2025-11-05 print — 2025-10-24 · S · Grossman Adam S · 6,000 shares
- 22 days before the 2025-05-07 print — 2025-04-15 · S · Grossman Adam S · 15,000 shares
- 22 days before the 2025-05-07 print — 2025-04-15 · S · Grossman Adam S · 6,000 shares
- 22 days before the 2025-08-06 print — 2025-07-15 · S · Grossman Adam S · 15,000 shares
- 22 days before the 2025-08-06 print — 2025-07-15 · S · Grossman Adam S · 6,000 shares
- 28 days before the 2026-01-12 print — 2025-12-15 · S · Grossman Adam S · 15,000 shares
- 28 days before the 2026-01-12 print — 2025-12-15 · S · Grossman Adam S · 6,000 shares
- 49 days before the 2025-05-07 print — 2025-03-19 · S · Grossman Adam S · 15,000 shares
- 49 days before the 2025-05-07 print — 2025-03-19 · S · Grossman Adam S · 6,000 shares
Interval to ADMA BIOLOGICS, INC.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 2within 10 days
- 8shortest, days
- 0no later print
- Grossman Adam S 2026-02-17 · S · 8 days before the 2026-02-25 print · President and CEO
- Grossman Adam S 2026-02-17 · S · 8 days before the 2026-02-25 print · President and CEO
Adoption dates ADMA BIOLOGICS, INC. states
- 2024-12-05 in 10 filings
- 2025-11-14 in 2 filings
Filing text: “10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024”
Reported results dates on file
- 2025-01-13
- 2025-03-03
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-01-12
- 2026-02-25
- 2026-05-06
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.